,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,357,2,1,,11112235,4075,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
1,410,1,5,,11112235,4075,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
2,411,2,1,,11112235,4075,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
3,421,1,3,,17389224,4075,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
4,426,1,2,,17389224,4075,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
5,427,1,1,,17389224,4075,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
6,433,1,1,,17389224,4075,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
7,434,1,2,,17389224,4075,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
8,435,1,2,,17389224,4075,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
9,444,1,1,,11112235,4075,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
10,445,3,1,,11112235,4075,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
11,445,3,1,,17389224,4075,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
12,446,1,1,,11112235,4075,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
13,447,1,1,,11112235,4075,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
14,448,1,2,,11112235,4075,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
15,450,1,2,,11112235,4075,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
16,451,1,2,,11112235,4075,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
17,526,1,1,,11112235,4075,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
18,530,1,1,,11112235,4075,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
19,530,1,1,,17389224,4075,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
20,540,1,1,,17389224,4075,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
21,541,1,1,,17389224,4075,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
22,542,1,1,,17389224,4075,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
23,543,1,1,,17389224,4075,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
24,544,2,1,,17389224,4075,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
25,545,1,1,,17389224,4075,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
26,546,1,1,,17389224,4075,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
27,584,1,3,,11112235,4075,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
28,584,1,3,,17389224,4075,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
29,585,1,4,,11112235,4075,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
30,585,1,4,,17389224,4075,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
31,587,1,5,,11112235,4075,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
32,588,1,4,,11112235,4075,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
33,589,1,3,,11112235,4075,Active,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
34,590,1,3,,11112235,4075,Active,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
35,591,1,4,,11112235,4075,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
36,592,1,6,,11112235,4075,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
37,593,1,4,,11112235,4075,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
38,594,1,4,,11112235,4075,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
39,595,1,3,,11112235,4075,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
40,595,1,3,,17389224,4075,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
41,596,1,2,,11112235,4075,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
42,596,1,2,,17389224,4075,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
43,597,1,3,,11112235,4075,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
44,603,1,2,,11112235,4075,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
45,603,1,2,,17389224,4075,Inconclusive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
46,605,1,2,,11112235,4075,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
47,605,1,2,,17389224,4075,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
48,607,1,3,,11112235,4075,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
49,654,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
50,655,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
51,656,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
52,657,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
53,658,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
54,659,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
55,660,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
56,661,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
57,662,1,1,,11112235,4075,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
58,662,1,1,,17389224,4075,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
59,663,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
60,664,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
61,665,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
62,666,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
63,667,1,1,,17389224,4075,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
64,875,1,2,,11112235,4075,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
65,875,1,2,,17389224,4075,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
66,880,2,1,,11112235,4075,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
67,880,2,1,,11112235,4075,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
68,880,2,1,,17389224,4075,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
69,880,2,1,,17389224,4075,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
70,880,2,1,,26752847,4075,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
71,880,2,1,,26752847,4075,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
72,881,2,2,,11112235,4075,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
73,881,2,2,,17389224,4075,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
74,883,1,3,,11112235,4075,Inconclusive,13699818.0,1559.0,12.5893,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
75,884,1,2,,11112235,4075,Inconclusive,13435386.0,1576.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
76,884,1,2,,17389224,4075,Active,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
77,885,1,2,,11112235,4075,Inactive,13435386.0,1576.0,7.9433,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
78,885,1,2,,17389224,4075,Inactive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
79,886,1,2,,11112235,4075,Active,122921310.0,,10.0,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
80,886,1,2,,11112235,4075,Active,122921311.0,,10.0,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
81,886,1,2,,17389224,4075,Active,122921310.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
82,886,1,2,,17389224,4075,Active,122921311.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
83,887,1,2,,11112235,4075,Inconclusive,1832253.0,246.0,15.8489,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
84,887,1,2,,17389224,4075,Inconclusive,1832253.0,246.0,31.6228,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
85,889,1,3,,11112235,4075,Inconclusive,1730092.0,840.0,7.9433,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
86,889,1,3,,17389224,4075,Inconclusive,1730092.0,840.0,25.1189,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
87,891,1,2,,11112235,4075,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
88,892,1,2,,11112235,4075,Inconclusive,159162802.0,,15.8489,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
89,892,1,2,,17389224,4075,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
90,893,1,2,,11112235,4075,Active,122921310.0,,10.0,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
91,893,1,2,,11112235,4075,Active,122921311.0,,10.0,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
92,893,1,2,,17389224,4075,Active,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
93,893,1,2,,17389224,4075,Active,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
94,894,2,1,,11112235,4075,Active,31542939.0,3248.0,11.2202,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
95,894,2,1,,17389224,4075,Inconclusive,31542939.0,3248.0,11.2202,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
96,896,1,3,,17389224,4075,Inactive,15431328.0,834.0,,Potency,Confirmation Concentration-Response Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
97,897,1,2,,17389224,4075,Inactive,1730092.0,840.0,,Potency,Confirmation Concentration-Response Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
98,899,1,2,,11112235,4075,Active,4503219.0,1557.0,5.0119,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
99,900,1,3,,11112235,4075,Active,15431328.0,834.0,6.3096,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
100,900,1,3,,17389224,4075,Active,15431328.0,834.0,12.5893,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
101,901,1,2,,11112235,4075,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
102,902,1,2,,11112235,4075,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
103,902,1,2,,17389224,4075,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
104,908,1,2,,17389224,4075,Inactive,1730092.0,840.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-7: Cysteine,Confirmatory,,
105,912,1,2,,11112235,4075,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
106,912,1,2,,17389224,4075,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
107,914,1,3,,11112235,4075,Inconclusive,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
108,915,1,3,,11112235,4075,Inconclusive,32879895.0,3091.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
109,919,1,2,,17389224,4075,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-7: Summary,Confirmatory,,
110,921,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
111,923,1,2,,11112235,4075,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
112,923,1,2,,17389224,4075,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
113,924,1,2,,11112235,4075,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
114,924,1,2,,17389224,4075,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
115,925,1,2,,11112235,4075,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
116,925,1,2,,17389224,4075,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
117,926,1,2,,11112235,4075,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
118,926,1,2,,17389224,4075,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
119,927,1,3,,11112235,4075,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
120,929,1,2,,17389224,4075,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-1: Cysteine,Confirmatory,,
121,938,1,2,,11112235,4075,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
122,938,1,2,,17389224,4075,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
123,946,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
124,947,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
125,948,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
126,955,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
127,960,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
128,961,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
129,962,1,2,,17389224,4075,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
130,963,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
131,964,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
132,965,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
133,966,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
134,967,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
135,968,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
136,969,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
137,970,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
138,971,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
139,972,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
140,973,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
141,974,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
142,975,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
143,976,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
144,977,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
145,978,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
146,979,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
147,980,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
148,981,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
149,982,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
150,983,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
151,984,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
152,985,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
153,986,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
154,987,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
155,988,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
156,989,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
157,993,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
158,994,1,2,,17389224,4075,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
159,995,1,2,,11112235,4075,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
160,995,1,2,,17389224,4075,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
161,996,1,2,,17389224,4075,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-1: Summary,Confirmatory,,
162,1030,2,1,,11112235,4075,Inconclusive,30582681.0,216.0,8.9125,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
163,1030,2,1,,17389224,4075,Inconclusive,30582681.0,216.0,14.9889,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
164,1332,1,1,,49698996,4075,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
165,1376,1,2,,49681712,4075,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
166,1379,1,2,,11112235,4075,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
167,1385,2,2,,49681712,4075,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
168,1422,1,1,,49681712,4075,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
169,1452,1,1,,11112235,4075,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
170,1452,1,1,,17389224,4075,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
171,1454,1,1,,11112235,4075,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
172,1457,1,1,,11112235,4075,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
173,1457,1,1,,17389224,4075,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
174,1458,1,1,,11112235,4075,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
175,1458,1,1,,17389224,4075,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
176,1465,1,1,,49681712,4075,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
177,1467,1,3,,11112235,4075,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
178,1469,1,1,,11112235,4075,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
179,1469,1,1,,17389224,4075,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
180,1469,1,1,,26752847,4075,Inconclusive,189491771.0,7068.0,125.89299999999999,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
181,1471,2,1,,11112235,4075,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
182,1471,2,1,,17389224,4075,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
183,1471,2,1,,26752847,4075,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
184,1476,2,1,,11112235,4075,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
185,1476,2,1,,17389224,4075,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
186,1478,2,1,,11112235,4075,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
187,1478,2,1,,17389224,4075,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
188,1479,1,2,,11112235,4075,Inconclusive,189491771.0,7068.0,14.1254,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
189,1479,1,2,,17389224,4075,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
190,1479,1,2,,26752847,4075,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
191,1487,1,1,,11112235,4075,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
192,1487,1,1,,26752847,4075,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
193,1490,2,1,,11112235,4075,Inconclusive,10954339.0,,28.1838,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
194,1490,2,1,,26752847,4075,Active,10954339.0,,44.6684,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
195,1511,1,3,,49681712,4075,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
196,1519,1,3,,11112235,4075,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
197,1529,1,1,,49681712,4075,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
198,1530,1,1,,49681712,4075,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
199,1531,1,1,,49681712,4075,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
200,1532,1,1,,49681712,4075,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
201,1554,1,1,,49681712,4075,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
202,1621,1,2,,49681712,4075,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
203,1626,1,2,,49681712,4075,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
204,1662,1,2,,49681712,4075,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
205,1663,1,2,,49681712,4075,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
206,1672,1,3,,49681712,4075,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
207,1688,1,1,,26752847,4075,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
208,1766,1,1,,11112235,4075,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
209,1766,1,1,,11112235,4075,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
210,1766,1,1,,26752847,4075,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
211,1766,1,1,,26752847,4075,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
212,1768,1,1,,11112235,4075,Inconclusive,18860839.0,4221.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
213,1768,1,1,,11112235,4075,Inconclusive,56550039.0,4297.0,12.5893,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
214,1768,1,1,,26752847,4075,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
215,1768,1,1,,26752847,4075,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
216,1813,1,2,,49681712,4075,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
217,1814,1,2,,49681712,4075,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
218,1832,2,1,,49681712,4075,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
219,1850,2,1,,49681712,4075,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
220,1851,1,2,,11112235,4075,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
221,1851,1,2,1.0,11112235,4075,Active,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
222,1851,1,2,2.0,11112235,4075,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
223,1851,1,2,3.0,11112235,4075,Inconclusive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
224,1851,1,2,4.0,11112235,4075,Inactive,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
225,1851,1,2,5.0,11112235,4075,Inconclusive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
226,1863,2,1,,49681712,4075,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
227,1865,1,1,,11112235,4075,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
228,1875,2,1,,49681712,4075,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
229,1885,2,1,,49681712,4075,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
230,1899,1,3,,49681712,4075,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
231,1903,2,3,,49681712,4075,Active,297591903.0,29031019.0,19.1,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
232,1906,1,3,,49681712,4075,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
233,1910,1,2,,49681712,4075,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
234,1947,1,2,,49681712,4075,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
235,1948,1,1,,11112235,4075,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
236,1948,1,1,,17389224,4075,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
237,1950,1,3,,49681712,4075,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
238,1956,1,1,,49681712,4075,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
239,1962,1,2,,49681712,4075,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
240,1974,1,2,,49681712,4075,Active,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
241,1979,1,1,,49681712,4075,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
242,1987,1,2,,49681712,4075,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
243,2016,1,3,,49681712,4075,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
244,2023,1,3,,49681712,4075,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
245,2025,1,3,,49681712,4075,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
246,2029,1,3,,49681712,4075,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
247,2052,2,1,,49681712,4075,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
248,2057,1,2,,49681712,4075,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
249,2066,1,4,,49681712,4075,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
250,2094,1,2,,49681712,4075,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
251,2094,1,2,,49681712,4075,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
252,2094,1,2,,49681712,4075,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
253,2097,1,2,,49681712,4075,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
254,2098,1,1,,49681712,4075,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
255,2099,1,1,,49681712,4075,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
256,2101,1,1,,11112235,4075,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
257,2101,1,1,,17389224,4075,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
258,2107,1,1,,11112235,4075,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
259,2107,1,1,,17389224,4075,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
260,2112,1,1,,11112235,4075,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
261,2112,1,1,,17389224,4075,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
262,2120,1,1,,17389224,4075,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
263,2129,1,2,,49681712,4075,Active,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
264,2130,1,3,,49681712,4075,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
265,2147,1,1,,11112235,4075,Inconclusive,221046486.0,,3.9811,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
266,2156,2,2,,49681712,4075,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
267,2174,1,3,,49681712,4075,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
268,2177,1,3,,49681712,4075,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
269,2216,1,3,,49681712,4075,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
270,2221,1,2,,49681712,4075,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
271,2227,1,2,,49681712,4075,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
272,2234,1,2,,49681712,4075,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
273,2235,1,2,,49681712,4075,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
274,2237,1,2,,49681712,4075,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
275,2239,1,2,,49681712,4075,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
276,2247,1,2,,49681712,4075,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
277,2280,2,3,,49681712,4075,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
278,2300,1,3,,49681712,4075,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
279,2391,1,1,,49681712,4075,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
280,2435,1,2,,49681712,4075,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
281,2445,1,2,,49681712,4075,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
282,2451,1,2,,11112235,4075,Active,122920737.0,,3.5397,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
283,2462,1,1,,49681712,4075,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
284,2462,1,1,,49681712,4075,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
285,2472,1,2,,11112235,4075,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
286,2501,1,1,,49681712,4075,Active,,,8.29,IC50,"A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen",Confirmatory,,
287,2517,2,1,,11112235,4075,Active,6980812.0,,1.9953,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
288,2517,2,1,,17389224,4075,Active,6980812.0,,7.0795,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
289,2528,1,2,,11112235,4075,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
290,2528,1,2,,26752847,4075,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
291,2546,1,1,,11112235,4075,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
292,2546,1,1,,17389224,4075,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
293,2546,1,1,,26752847,4075,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
294,2549,1,1,,11112235,4075,Active,282403581.0,,3.9811,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
295,2549,1,1,,17389224,4075,Active,282403581.0,,7.0795,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
296,2550,1,3,,49681712,4075,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
297,2551,1,1,,11112235,4075,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
298,2551,1,1,,17389224,4075,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
299,2551,1,1,,26752847,4075,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
300,2553,1,2,,49681712,4075,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
301,2557,1,3,,49681712,4075,Active,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
302,2563,1,1,,49681712,4075,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
303,2606,1,2,,49681712,4075,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
304,2629,1,1,,49681712,4075,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
305,2642,1,2,,49681712,4075,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
306,2648,1,2,,49681712,4075,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
307,2650,2,1,,49681712,4075,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
308,2661,1,1,,49681712,4075,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
309,2690,1,2,,49681712,4075,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
310,2716,1,1,,49681712,4075,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
311,2717,1,2,,49681712,4075,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
312,2718,1,1,,49681712,4075,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
313,2751,2,2,,49681712,4075,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
314,2796,1,4,,49681712,4075,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
315,2797,1,2,,49681712,4075,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
316,43581,3,7,,103194285,4075,Unspecified,,,,,Inhibition of beta-lactamase at 100 uM,Other,14521410.0,
317,52790,3,7,,103194285,4075,Unspecified,,,,,Inhibition of chymotrypsin at 250 uM,Other,14521410.0,
318,77141,3,3,,103194285,4075,Unspecified,,,,,Tested for cecal ulceration in diarrhea at 60 umol concentration of compound,Other,6136612.0,
319,77142,3,3,,103194285,4075,Unspecified,,,,,Tested for cecal ulceration in necropsy at 60 umol concentration of compound,Other,6136612.0,
320,77143,3,3,,103194285,4075,Unspecified,,,,,Tested for cecal ulceration with mortality at 60 umol concentration of compound,Other,6136612.0,
321,78212,3,3,,103194285,4075,Unspecified,,,,,Tested for mean score after quantitative histological evaluation result in guinea pig,Other,6136612.0,
322,80567,3,3,,103194285,4075,Unspecified,,,,,Tested for weight loss in guinea pig at 60 umol concentration of compound,Other,6136612.0,
323,106805,3,8,,103194285,4075,Unspecified,,,,,Compound was tested for the inhibition of malate dehydrogenase (MDH) at 200 uM,Other,14521410.0,
324,179007,3,4,,103194285,4075,Unspecified,,,,,Fecal recovery in colostomized rats at 2 hr intervals for 48 h,Other,8277502.0,
325,179008,3,4,,103194285,4075,Unspecified,,,,,Fecal recovery in non-colostomized rats at 2 hr intervals for 48 h,Other,8277502.0,
326,190858,3,5,,103194285,4075,Unspecified,,,,,Urinary recovery in colostomized rats at 2 hr intervals for 48 h,Other,8277502.0,
327,190859,3,5,,103194285,4075,Unspecified,,,,,Urinary recovery in non-colostomized rats at 2 hr intervals for 48 h,Other,8277502.0,
328,293912,3,4,,103194285,4075,Unspecified,,,,,"Partition coefficient, log P in n-octanol/phosphate buffer at pH 7.4",Other,17258353.0,
329,293915,3,3,,103194285,4075,Unspecified,,,,,"Ulcerogenic effect in Wistar rat at 2290 mg/kg, po by Rainsford's cold stress method relative to control",Other,17258353.0,
330,293918,3,4,,103194285,4075,Unspecified,,,,,Antiinflammatory activity in Wistar rat colon assessed as myeloperoxidase activity per 100 mg tissue,Other,17258353.0,
331,293919,3,3,,103194285,4075,Unspecified,,,,,Antiarthritic activity in Freund's adjuvant-induced arthritis Wistar rat model after 13 days,Other,17258353.0,
332,293920,3,3,,103194285,4075,Unspecified,,,,,Antiarthritic activity in Freund's adjuvant-induced arthritis Wistar rat model after 21 days,Other,17258353.0,
333,299083,3,4,,103194285,4075,Unspecified,,,,,"Partition coefficient, log P at pH 7.4",Other,17280832.0,
334,299084,3,3,,103194285,4075,Unspecified,,,,,"Ulcerogenic activity in Wistar rat assessed as ulcer index at 2290 mg/kg, po",Other,17280832.0,
335,299085,3,3,,103194285,4075,Active,,,,,Decrease in inflammation in TNBS-induced Wistar rat colitis model after 24 to 48 hrs,Other,17280832.0,
336,299836,3,4,,103194285,4075,Unspecified,,,,,"Partition coefficient, log P in n-octanol/phosphate buffer at pH 7.4",Other,17499512.0,
337,299837,3,3,,103194285,4075,Unspecified,,,,,"Ulcerogenic activity in Wistar rat at 2290 mg/kg, po by cold stress method relative to control",Other,17499512.0,
338,320706,9,3,,103194285,4075,Unspecified,,,10000.0,IC50,Inhibition of PAD4 by ABPP-based assay,Confirmatory,17964793.0,
339,337238,7,6,,103194285,4075,Unspecified,1352359.0,13649.0,,,Inhibition of mouse EGFR by liquid scintillation counting,Other,2614420.0,
340,404304,3,10,,103194285,4075,Unspecified,308153583.0,1244.0,,,Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control,Other,18457386.0,
341,417721,3,3,,103194285,4075,Active,,,,,Antiinflammatory activity against TNBS-induced Wistar rat colitis model assessed as decrease in severity of inflammation treated po 3 days after TNBS induction measured on day 7,Other,18472188.0,
342,417722,3,3,,103194285,4075,Active,,,,,Antiinflammatory activity against TNBS-induced Wistar rat colitis model assessed as decrease in severity of inflammation treated rectally 3 days after TNBS induction measured on day 7,Other,18472188.0,
343,417725,3,3,,103194285,4075,Unspecified,,,,,Antiinflammatory activity against TNBS-induced po dosed Wistar rat colitis model assessed as inhibition of MPO activity in neutrophils per 100 mg of tissue,Other,18472188.0,
344,417729,3,3,,103194285,4075,Unspecified,,,,,Ulcerogenic effect in rat colon assessed as ulcer index at 1154.30 mg/kg by Rainsford's cold stress method,Other,18472188.0,
345,425628,3,3,,103194285,4075,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
346,425629,3,3,,103194285,4075,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
347,425630,5,1,,103194285,4075,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
348,425631,5,1,,103194285,4075,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method,Other,18070971.0,
349,425632,5,1,,103194285,4075,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test,Other,18070971.0,
350,434955,1,2,,49681712,4075,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
351,434962,1,2,,49681712,4075,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
352,434989,1,1,,49681712,4075,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
353,435030,1,2,,49681712,4075,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
354,435030,1,2,,49681712,4075,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
355,436230,3,3,,103194285,4075,Unspecified,,,,,"Gastrointestinal toxicity in Wistar rat assessed as ulcer index at 1154.3 mg/kg, po by Rainsford's cold stress method",Other,19442419.0,
356,436237,3,3,,103194285,4075,Unspecified,,,,,Antiarthritic activity against Freund's adjuvant-induced arthritis in Wistar rat assessed as reduction in paw volume administered 13 days after Freund's adjuvant challenge measured on day 21,Other,19442419.0,
357,436411,8,1,,103194285,4075,Unspecified,,,,,Aqueous solubility of the compound,Other,19442419.0,
358,436412,3,3,,103194285,4075,Unspecified,,,,,"Partition coefficient, log P in n-octanol/phosphate buffer of pH 7.4",Other,19442419.0,
359,445445,7,1,,103194285,4075,Unspecified,,,,,Permeability at pH 6.5 by PAMPA method,Other,19947605.0,
360,445446,3,4,,103194285,4075,Unspecified,,,,,Oral bioavailability in human,Other,19947605.0,
361,449728,1,2,,49681712,4075,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
362,449739,1,2,,49681712,4075,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
363,449762,1,2,,49681712,4075,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
364,449768,1,1,,49681712,4075,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
365,463079,1,2,,49681712,4075,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
366,463082,1,1,,49681712,4075,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
367,463111,1,1,,49681712,4075,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
368,463141,1,2,,49681712,4075,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
369,463165,1,1,,49681712,4075,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
370,463210,1,2,,49681712,4075,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
371,485270,1,1,,49681712,4075,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
372,485272,1,1,,49681712,4075,Active,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
373,485275,1,3,,49681712,4075,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
374,485281,1,1,,11112235,4075,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
375,485290,1,1,,11112235,4075,Inconclusive,20150581.0,,1.0,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
376,485290,1,1,,17389224,4075,Inconclusive,20150581.0,,2.5119,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
377,485290,1,1,,26752847,4075,Inconclusive,20150581.0,,11.2202,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
378,485317,1,2,,49681712,4075,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
379,485350,1,2,,92125984,4075,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
380,488847,1,3,,49681712,4075,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
381,488890,1,2,,49681712,4075,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
382,488922,1,2,,49681712,4075,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
383,488975,1,2,,49681712,4075,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
384,488977,1,2,,49681712,4075,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
385,492967,1,2,,92125984,4075,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
386,493033,1,2,,92125984,4075,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
387,493140,1,1,,103914626,4075,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
388,504327,1,1,,11112235,4075,Inconclusive,153791535.0,2648.0,7.9433,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
389,504332,1,1,,11112235,4075,Active,168985070.0,,3.1623,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
390,504406,1,1,,49681712,4075,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
391,504408,2,1,,49681712,4075,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
392,504749,1,3,,26752847,4075,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
393,504749,1,3,,104171289,4075,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
394,504749,1,3,1.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
395,504749,1,3,2.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
396,504749,1,3,3.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
397,504749,1,3,4.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
398,504749,1,3,5.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
399,504749,1,3,6.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
400,504749,1,3,7.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
401,504749,1,3,8.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
402,504749,1,3,9.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
403,504749,1,3,10.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
404,504749,1,3,11.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
405,504749,1,3,12.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
406,504749,1,3,13.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
407,504749,1,3,14.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
408,504749,1,3,15.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
409,504749,1,3,16.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
410,504749,1,3,17.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
411,504749,1,3,18.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
412,504749,1,3,19.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
413,504749,1,3,20.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
414,504749,1,3,21.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
415,504749,1,3,22.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
416,504749,1,3,23.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
417,504749,1,3,24.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
418,504749,1,3,25.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
419,504749,1,3,26.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
420,504749,1,3,27.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
421,504749,1,3,28.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
422,504749,1,3,29.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
423,504749,1,3,30.0,104171289,4075,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
424,504749,1,3,31.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
425,504749,1,3,32.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
426,504749,1,3,33.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
427,504749,1,3,34.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
428,504749,1,3,35.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
429,504749,1,3,36.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
430,504749,1,3,37.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
431,504749,1,3,38.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
432,504749,1,3,39.0,26752847,4075,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
433,504749,1,3,40.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
434,504749,1,3,41.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
435,504749,1,3,42.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
436,504749,1,3,43.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
437,504749,1,3,44.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
438,504749,1,3,45.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
439,504749,1,3,46.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
440,504749,1,3,47.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
441,504749,1,3,48.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
442,504749,1,3,49.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
443,504749,1,3,50.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
444,504749,1,3,51.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
445,504749,1,3,52.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
446,504749,1,3,53.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
447,504749,1,3,54.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
448,504749,1,3,55.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
449,504749,1,3,56.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
450,504749,1,3,57.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
451,504749,1,3,58.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
452,504749,1,3,59.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
453,504749,1,3,60.0,104171289,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
454,504749,1,3,61.0,26752847,4075,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
455,504832,1,1,,104171289,4075,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
456,504834,1,1,,104171289,4075,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
457,504847,1,1,,11112235,4075,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
458,504847,1,1,,104171289,4075,Active,63054845.0,7421.0,44.6684,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
459,504865,1,1,,11112235,4075,Active,118600387.0,7398.0,11.2202,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
460,504865,1,1,,104171289,4075,Active,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
461,540209,4,3,,103194285,4075,Unspecified,,,,,Volume of distribution at steady state in human after iv administration,Other,18426954.0,
462,540210,4,3,,103194285,4075,Unspecified,,,,,Clearance in human after iv administration,Other,18426954.0,
463,540211,2,5,,103194285,4075,Unspecified,,,,,Fraction unbound in human after iv administration,Other,18426954.0,
464,540212,4,3,,103194285,4075,Unspecified,,,,,Mean residence time in human after iv administration,Other,18426954.0,
465,540213,4,3,,103194285,4075,Unspecified,,,,,Half life in human after iv administration,Other,18426954.0,
466,540299,1,2,,92125984,4075,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
467,588211,2,3,,103194285,4075,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
468,588212,2,3,,103194285,4075,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
469,588213,2,3,,103194285,4075,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
470,588214,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, liver enzyme composite activity",Other,16472241.0,
471,588215,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, alkaline phosphatase increase",Other,16472241.0,
472,588216,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",Other,16472241.0,
473,588217,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",Other,16472241.0,
474,588218,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, lactate dehydrogenase (LDH) increase",Other,16472241.0,
475,588219,2,3,,103194285,4075,Unspecified,,,,,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",Other,16472241.0,
476,588511,1,2,,49681712,4075,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
477,588513,1,1,,17389224,4075,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
478,588513,1,1,,26752847,4075,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
479,588514,1,1,,17389224,4075,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
480,588514,1,1,,26752847,4075,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
481,588515,1,1,,17389224,4075,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
482,588515,1,1,,26752847,4075,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
483,588516,1,1,,17389224,4075,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
484,588516,1,1,,26752847,4075,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
485,588519,1,2,,92125984,4075,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
486,588526,1,1,,17389224,4075,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
487,588526,1,1,,26752847,4075,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
488,588527,1,1,,17389224,4075,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
489,588527,1,1,,26752847,4075,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
490,588532,1,1,,17389224,4075,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
491,588532,1,1,,26752847,4075,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
492,588533,1,1,,17389224,4075,Inconclusive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
493,588533,1,1,,26752847,4075,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
494,588534,1,1,,17389224,4075,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
495,588534,1,1,,26752847,4075,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
496,588535,1,1,,17389224,4075,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
497,588535,1,1,,26752847,4075,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
498,588536,1,1,,17389224,4075,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
499,588536,1,1,,26752847,4075,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
500,588537,1,1,,17389224,4075,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
501,588537,1,1,,26752847,4075,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
502,588541,1,1,,17389224,4075,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
503,588541,1,1,,26752847,4075,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
504,588543,1,1,,17389224,4075,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
505,588543,1,1,,26752847,4075,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
506,588544,1,1,,17389224,4075,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
507,588544,1,1,,26752847,4075,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
508,588545,1,1,,17389224,4075,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
509,588545,1,1,,26752847,4075,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
510,588546,1,1,,17389224,4075,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
511,588546,1,1,,26752847,4075,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
512,588547,1,1,,17389224,4075,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
513,588547,1,1,,26752847,4075,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
514,588579,1,1,,11112235,4075,Active,7705344.0,51426.0,1.0621,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
515,588579,1,1,,104171289,4075,Active,7705344.0,51426.0,5.9728,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
516,588627,1,1,,49681712,4075,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
517,588675,1,1,,49681712,4075,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
518,588676,1,1,,49681712,4075,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
519,588834,2,1,,17389224,4075,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
520,588834,2,1,,26752847,4075,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
521,602314,1,2,,92125984,4075,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
522,602332,1,1,,11112235,4075,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
523,602332,1,1,,104171289,4075,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
524,602687,1,4,,103194285,4075,Active,,,,,Reduction in TNBS-induced colitis in intrarectally dosed C57Bl6 mouse experimental colitis model assessed as reduction in colitis macroscopic score at 150 mg/kg mixed in food and provided as ad libitum during course of experiment,Other,21612933.0,
525,602690,1,4,,103194285,4075,Active,,,,,Reduction in TNF mRNA expression in C57Bl6 mouse intrarectally dosed TNBS-induced experimental colitis model at 150 mg/kg mixed in food and provided as ad libitum during course of experiment,Other,21612933.0,
526,602691,1,4,,103194285,4075,Active,,,,,Reduction in IL1-beta mRNA expression in C57Bl6 mouse intrarectally dosed TNBS-induced experimental colitis model at 150 mg/kg mixed in food and provided as ad libitum during course of experiment,Other,21612933.0,
527,622159,6,5,,103194285,4075,Unspecified,12585385.0,23657.0,1000.0,IC50,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,Confirmatory,21889337.0,
528,624030,1,2,,104171289,4075,Inconclusive,160794.0,,32.1968,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
529,624031,1,2,,104171289,4075,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
530,624032,1,2,,104171289,4075,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
531,624044,1,2,,104171289,4075,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
532,624170,1,1,,104171289,4075,Active,71051501.0,2744.0,15.8489,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
533,624172,1,1,,104171289,4075,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
534,624173,1,3,,104171289,4075,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
535,624296,1,1,,26752847,4075,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
536,624296,1,1,,104171289,4075,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
537,624297,1,1,,26752847,4075,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
538,624297,1,1,,104171289,4075,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
539,624349,1,2,,92308491,4075,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
540,624349,1,2,,92309165,4075,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
541,624349,1,2,,121363655,4075,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
542,624609,1,9,,103194285,4075,Unspecified,29840832.0,54578.0,,,Specific activity of expressed human recombinant UGT1A6,Other,10836148.0,
543,624612,1,9,,103194285,4075,Unspecified,29839451.0,54600.0,,,Specific activity of expressed human recombinant UGT1A9,Other,10836148.0,
544,625279,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
545,625280,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
546,625281,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
547,625282,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
548,625283,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
549,625284,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
550,625285,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
551,625286,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
552,625287,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
553,625288,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
554,625289,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
555,625290,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
556,625291,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
557,625292,1,3,,103194285,4075,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
558,625305,3,2,,103194285,4075,Unspecified,,,16000.0,IC50,Antiinflammatory activity against TNF-alpha-induced VCAM-1 protein expression in HAEC by ELISA,Confirmatory,21955679.0,
559,639952,1,4,,103194285,4075,Active,,,,,Inhibition of TNF-alpha-induced NF-kappaB activation in human HCT116 cells at 1 mM after 6 hrs by luciferase reporter gene assay,Other,22154834.0,
560,639967,1,4,,103194285,4075,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in rat assessed as decrease in COX2 protein at 30 mM administered rectally QD for 6 days,Other,22154834.0,
561,639968,1,4,,103194285,4075,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in rat assessed as healing of damaged colon at 30 mM administered rectally QD for 6 days,Other,22154834.0,
562,639969,1,4,,103194285,4075,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in rat assessed as decrease in myeloperoxidase activity at 30 mM administered rectally QD for 6 days,Other,22154834.0,
563,639970,1,4,,103194285,4075,Active,,,,,Antiinflammatory activity against trinitrobenzenesulfonic acid-induced colitis in rat assessed as decrease in CINC2 protein expression at 30 mM administered rectally QD for 6 days,Other,22154834.0,
564,651631,4,1,,144203935,4075,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
565,651631,4,1,,144208808,4075,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
566,651631,4,1,,144213442,4075,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
567,651632,4,1,,144203935,4075,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
568,651632,4,1,,144208808,4075,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
569,651632,4,1,,144213442,4075,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
570,651633,4,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
571,651633,4,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
572,651633,4,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
573,651634,4,1,,144203935,4075,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
574,651634,4,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
575,651634,4,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
576,651635,1,3,,11112235,4075,Inconclusive,171543895.0,6311.0,17.7828,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
577,651741,1,1,,17389224,4075,Inactive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
578,651741,1,1,,144203935,4075,Inactive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
579,651743,1,1,,17389224,4075,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
580,651743,1,1,,26752847,4075,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
581,651749,1,1,,17389224,4075,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
582,651749,1,1,,26752847,4075,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
583,651751,1,1,,17389224,4075,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
584,651751,1,1,,26752847,4075,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
585,651754,1,1,,17389224,4075,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
586,651755,1,1,,17389224,4075,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
587,651757,1,1,,17389224,4075,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
588,651758,1,1,,17389224,4075,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
589,651777,1,1,,17389224,4075,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
590,651777,1,1,,26752847,4075,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
591,651778,1,1,,17389224,4075,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
592,651778,1,1,,26752847,4075,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
593,651802,1,1,,17389224,4075,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
594,651828,1,2,,92308491,4075,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
595,651828,1,2,,92309165,4075,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
596,651838,1,1,,17389224,4075,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
597,651838,1,1,,26752847,4075,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
598,651838,1,1,1.0,17389224,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
599,651838,1,1,1.0,26752847,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
600,651838,1,1,2.0,17389224,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
601,651838,1,1,2.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
602,651838,1,1,3.0,17389224,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
603,651838,1,1,3.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
604,651838,1,1,4.0,17389224,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
605,651838,1,1,4.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
606,651838,1,1,5.0,17389224,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
607,651838,1,1,5.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
608,651838,1,1,6.0,17389224,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
609,651838,1,1,6.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
610,651838,1,1,7.0,17389224,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
611,651838,1,1,7.0,26752847,4075,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
612,651838,1,1,8.0,17389224,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
613,651838,1,1,8.0,26752847,4075,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
614,652048,1,2,,144203935,4075,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
615,652051,1,1,,144203935,4075,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
616,686977,2,1,,49698996,4075,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
617,686978,1,1,,144203935,4075,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
618,686979,1,1,,144203935,4075,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
619,704198,1,2,,103194285,4075,Unspecified,,,,,Anticolitis activity in TNBS-induced C57Bl6 mouse experimental colitis model assessed as reduction colitis macroscopic scores at 150 mg/kg dosed as Pentasa formulation dosed 3 days before colitis induction,Other,23017078.0,
620,716597,1,2,,103194285,4075,Unspecified,,,,,Antiinflammatory activity in LPS-activated mouse RAW264.7 cells assessed as inhibition of LPS induced TNFalpha production treated 30 mins prior to LPS challenge measured after 6 hrs by RT-PCR analysis,Other,22963087.0,
621,716598,1,2,,103194285,4075,Unspecified,,,,,Cytotoxicity against MDCK cells at 100 uM,Other,22963087.0,
622,716602,1,2,,103194285,4075,Unspecified,,,,,Antiinflammatory activity in LPS-activated mouse RAW264.7 cells assessed as inhibition of LPS induced IL6 production treated 30 mins prior to LPS challenge measured after 6 hrs by RT-PCR analysis,Other,22963087.0,
623,716610,1,4,,103194285,4075,Active,,,,,"Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in BALB/c mouse assessed as protection from virus-induced death at 12 umol/kg/day, intranasally administered bid on days 1 to 4 and day 0 of infection measured over 14 days",Other,22963087.0,
624,716613,1,4,,103194285,4075,Unspecified,,,100.0,EC50,Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathic effect,Confirmatory,22963087.0,
625,716614,2,1,,103194285,4075,Unspecified,84028231.0,,100.0,IC50,Inhibition of Influenza A virus A/WSN/1933(H1N1)) neuraminidase in the presence of 2'-(4-methyl-umbelliferyl)-alphaD-N-acetylneuraminic acid substrate after 10 mins by fluorometric assay,Confirmatory,22963087.0,
626,720516,2,1,,144203935,4075,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
627,720516,2,1,,144208808,4075,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
628,720516,2,1,,144213442,4075,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
629,720532,1,1,,11112235,4075,Inconclusive,420597.0,,14.1254,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
630,720532,1,1,,144203935,4075,Inconclusive,420597.0,,17.7828,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
631,720533,1,1,,11112235,4075,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
632,720533,1,1,,144203935,4075,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
633,720552,2,1,,144203935,4075,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
634,720552,2,1,,144208808,4075,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
635,720552,2,1,,144213442,4075,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
636,720554,1,3,,92308491,4075,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
637,720634,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
638,720634,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
639,720634,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
640,720635,2,1,,144203935,4075,Inconclusive,,,10.5909,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
641,720635,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
642,720635,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
643,720636,1,1,,17389224,4075,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
644,720636,1,1,,144203935,4075,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
645,720637,2,1,,144203935,4075,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
646,720637,2,1,,144208808,4075,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
647,720637,2,1,,144213442,4075,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
648,720641,1,2,,92308491,4075,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
649,720641,1,2,,92309165,4075,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
650,720652,1,1,,17389224,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
651,720653,1,1,,17389224,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
652,720653,1,1,,26752847,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
653,720659,1,1,,17389224,4075,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
654,720659,1,1,,26752847,4075,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
655,720674,2,2,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
656,720674,2,2,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
657,720674,2,2,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
658,720675,2,2,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
659,720675,2,2,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
660,720675,2,2,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
661,720678,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
662,720678,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
663,720678,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
664,720679,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
665,720679,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
666,720679,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
667,720680,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
668,720680,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
669,720680,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
670,720681,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
671,720681,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
672,720681,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
673,720682,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
674,720682,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
675,720682,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
676,720683,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
677,720683,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
678,720683,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
679,720684,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
680,720684,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
681,720684,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
682,720685,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
683,720685,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
684,720685,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
685,720686,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
686,720686,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
687,720686,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
688,720687,2,2,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
689,720687,2,2,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
690,720687,2,2,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
691,720691,4,1,,144203935,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
692,720691,4,1,,144208808,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
693,720691,4,1,,144213442,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
694,720692,3,1,,144203935,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
695,720692,3,1,,144208808,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
696,720692,3,1,,144213442,4075,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
697,720693,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
698,720693,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
699,720693,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
700,720717,1,3,,92125984,4075,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
701,720717,1,3,,92308491,4075,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
702,720717,1,3,,92309165,4075,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
703,720719,2,1,,144203935,4075,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
704,720719,2,1,,144208808,4075,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
705,720719,2,1,,144213442,4075,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
706,720725,2,1,,144203935,4075,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
707,720725,2,1,,144208808,4075,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
708,720725,2,1,,144213442,4075,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
709,731789,1,2,,103194285,4075,Inactive,,,,,Antiinflammatory activity in DSS-induced C57Bl/6 mouse colitis model assessed as inhibition IL-1beta level in colonic homogenate at 400 mg/kg/day administered intragastrically for 7 days,Other,23416190.0,
710,731790,1,2,,103194285,4075,Active,,,,,Antiinflammatory activity in DSS-induced C57Bl/6 mouse colitis model assessed as inhibition MPO activity in colonic homogenate at 400 mg/kg/day administered intragastrically for 7 days,Other,23416190.0,
711,731799,1,2,,103194285,4075,Active,,,,,Increase in PPAR-gamma mRNA transcript level in human macrophages at 30 mM by quantitative PCR analysis,Other,23416190.0,
712,743012,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
713,743012,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
714,743012,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
715,743014,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
716,743014,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
717,743014,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
718,743015,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
719,743015,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
720,743015,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
721,743033,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
722,743033,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
723,743033,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
724,743035,2,1,,144203935,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
725,743035,2,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
726,743035,2,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
727,743036,2,1,,144203935,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
728,743036,2,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
729,743036,2,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
730,743040,3,1,,144203935,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
731,743040,3,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
732,743040,3,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
733,743041,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
734,743041,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
735,743041,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
736,743042,3,1,,144203935,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
737,743042,3,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
738,743042,3,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
739,743053,2,1,,144203935,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
740,743053,2,1,,144208808,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
741,743053,2,1,,144213442,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
742,743054,2,1,,144203935,4075,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
743,743054,2,1,,144208808,4075,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
744,743054,2,1,,144213442,4075,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
745,743063,2,1,,144203935,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
746,743063,2,1,,144208808,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
747,743063,2,1,,144213442,4075,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
748,743064,3,1,,144203935,4075,Inconclusive,,,0.0021,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
749,743064,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
750,743064,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
751,743065,3,1,,144203935,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
752,743065,3,1,,144208808,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
753,743065,3,1,,144213442,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
754,743066,3,1,,144203935,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
755,743066,3,1,,144208808,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
756,743066,3,1,,144213442,4075,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
757,743067,2,1,,144203935,4075,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
758,743067,2,1,,144208808,4075,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
759,743067,2,1,,144213442,4075,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
760,743069,2,1,,144203935,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
761,743069,2,1,,144208808,4075,Inactive,348019627.0,2099.0,21.6906,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
762,743069,2,1,,144213442,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
763,743074,2,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
764,743074,2,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
765,743074,2,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
766,743075,2,1,,144203935,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
767,743075,2,1,,144208808,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
768,743075,2,1,,144213442,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
769,743077,2,1,,144203935,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
770,743077,2,1,,144208808,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
771,743077,2,1,,144213442,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
772,743078,2,1,,144203935,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
773,743078,2,1,,144208808,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
774,743078,2,1,,144213442,4075,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
775,743079,3,1,,144203935,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
776,743079,3,1,,144208808,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
777,743079,3,1,,144213442,4075,Active,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
778,743080,3,1,,144203935,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
779,743080,3,1,,144208808,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
780,743080,3,1,,144213442,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
781,743081,3,1,,144203935,4075,Inconclusive,,,2.1132,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
782,743081,3,1,,144208808,4075,Inconclusive,,,67.9623,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
783,743081,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
784,743083,3,1,,144203935,4075,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
785,743083,3,1,,144208808,4075,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
786,743083,3,1,,144213442,4075,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
787,743084,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
788,743084,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
789,743084,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
790,743085,3,1,,144203935,4075,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
791,743085,3,1,,144208808,4075,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
792,743085,3,1,,144213442,4075,Inconclusive,51095037.0,196.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
793,743086,3,1,,144203935,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
794,743086,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
795,743086,3,1,,144213442,4075,Inconclusive,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
796,743091,2,1,,144203935,4075,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
797,743091,2,1,,144208808,4075,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
798,743091,2,1,,144213442,4075,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
799,743094,3,1,,144203935,4075,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
800,743094,3,1,,144208808,4075,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
801,743094,3,1,,144213442,4075,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
802,743122,2,1,,144203935,4075,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
803,743122,2,1,,144208808,4075,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
804,743122,2,1,,144213442,4075,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
805,743139,2,1,,144203935,4075,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
806,743139,2,1,,144208808,4075,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
807,743139,2,1,,144213442,4075,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
808,743140,2,1,,144203935,4075,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
809,743140,2,1,,144208808,4075,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
810,743140,2,1,,144213442,4075,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
811,743191,3,1,,144208808,4075,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
812,743191,3,1,,144213442,4075,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
813,743191,3,1,,170464840,4075,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
814,743194,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
815,743194,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
816,743194,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
817,743199,2,1,,144208808,4075,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
818,743199,2,1,,144213442,4075,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
819,743199,2,1,,170464840,4075,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
820,743202,4,1,,144208808,4075,Inconclusive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
821,743202,4,1,,144213442,4075,Inconclusive,20149576.0,4780.0,24.3365,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
822,743202,4,1,,170464840,4075,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
823,743203,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
824,743203,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
825,743203,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
826,743209,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
827,743209,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
828,743209,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
829,743210,4,1,,144208808,4075,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
830,743210,4,1,,144213442,4075,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
831,743210,4,1,,170464840,4075,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
832,743211,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
833,743211,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
834,743211,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
835,743212,3,1,,144208808,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
836,743212,3,1,,144213442,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
837,743212,3,1,,170464840,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
838,743213,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
839,743213,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
840,743213,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
841,743215,3,1,,144208808,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
842,743215,3,1,,144213442,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
843,743215,3,1,,170464840,4075,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
844,743217,3,1,,144208808,4075,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
845,743217,3,1,,144213442,4075,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
846,743217,3,1,,170464840,4075,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
847,743218,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
848,743218,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
849,743218,3,1,,170464840,4075,Inconclusive,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
850,743219,3,1,,144208808,4075,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
851,743219,3,1,,144213442,4075,Inconclusive,20149576.0,4780.0,24.3365,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
852,743219,3,1,,170464840,4075,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
853,743220,3,1,,144208808,4075,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
854,743220,3,1,,144213442,4075,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
855,743220,3,1,,170464840,4075,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
856,743221,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
857,743221,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
858,743221,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
859,743222,3,1,,144208808,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
860,743222,3,1,,144213442,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
861,743222,3,1,,170464840,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
862,743223,3,1,,144208808,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
863,743223,3,1,,144213442,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
864,743223,3,1,,170464840,4075,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
865,743224,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
866,743224,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
867,743224,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
868,743225,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
869,743225,3,1,,144213442,4075,Inconclusive,,,2.1872,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
870,743225,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
871,743226,2,1,,144208808,4075,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
872,743226,2,1,,144213442,4075,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
873,743226,2,1,,170464840,4075,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
874,743227,2,1,,144208808,4075,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
875,743227,2,1,,144213442,4075,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
876,743227,2,1,,170464840,4075,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
877,743228,3,1,,144208808,4075,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
878,743228,3,1,,144213442,4075,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
879,743228,3,1,,170464840,4075,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
880,743239,2,1,,144208808,4075,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
881,743239,2,1,,144213442,4075,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
882,743239,2,1,,170464840,4075,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
883,743240,2,1,,144208808,4075,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
884,743240,2,1,,144213442,4075,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
885,743240,2,1,,170464840,4075,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
886,743241,2,1,,144208808,4075,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
887,743241,2,1,,144213442,4075,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
888,743241,2,1,,170464840,4075,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
889,743242,2,1,,144208808,4075,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
890,743242,2,1,,144213442,4075,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
891,743242,2,1,,170464840,4075,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
892,743244,1,1,,144203935,4075,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
893,743268,1,1,,172080202,4075,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
894,743270,1,1,,172080202,4075,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
895,743271,1,1,,172080202,4075,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
896,743272,1,1,,172080202,4075,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
897,743281,1,1,,46386870,4075,Inactive,1778357.0,22341.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
898,743281,1,1,,46386870,4075,Inactive,219520294.0,8828.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
899,743288,1,1,,17389224,4075,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
900,743288,1,1,,26752847,4075,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
901,743292,1,1,,17389224,4075,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
902,743292,1,1,,26752847,4075,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
903,1079931,1,1,,103194285,4075,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
904,1079932,1,1,,103194285,4075,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
905,1079933,1,1,,103194285,4075,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
906,1079934,1,1,,103194285,4075,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
907,1079935,1,1,,103194285,4075,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
908,1079936,1,1,,103194285,4075,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
909,1079937,1,1,,103194285,4075,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
910,1079938,1,1,,103194285,4075,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
911,1079939,1,1,,103194285,4075,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
912,1079940,1,1,,103194285,4075,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
913,1079941,1,1,,103194285,4075,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
914,1079942,1,1,,103194285,4075,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
915,1079943,1,1,,103194285,4075,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
916,1079944,1,1,,103194285,4075,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
917,1079945,1,1,,103194285,4075,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
918,1079946,1,1,,103194285,4075,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
919,1079947,1,1,,103194285,4075,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
920,1079948,1,1,,103194285,4075,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
921,1079949,1,1,,103194285,4075,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
922,1094682,1,2,,103194285,4075,Unspecified,,,,,Toxicity in po dosed Rattus norvegicus (rat),Other,,
923,1117298,1,2,,170464840,4075,Inactive,,,0.7079,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
924,1117301,1,2,,170464840,4075,Inactive,,,2.2387,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel",Confirmatory,,
925,1117302,1,2,,170464840,4075,Inactive,,,0.2818,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel",Confirmatory,,
926,1117303,1,2,,170464840,4075,Inactive,,,28.19,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel",Confirmatory,,
927,1117304,1,2,,170464840,4075,Active,,,28.1838,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
928,1117305,1,2,,170464840,4075,Inactive,,,31.6228,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
929,1117310,1,1,,170464840,4075,Inactive,,,0.707946,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
930,1117311,1,1,,170464840,4075,Inactive,,,2.2387200000000003,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel",Confirmatory,,
931,1117312,1,1,,170464840,4075,Active,,,31.6228,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
932,1117314,1,1,,170464840,4075,Inactive,,,28.1838,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
933,1117315,1,1,,170464840,4075,Inactive,,,0.28183800000000003,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel",Confirmatory,,
934,1117318,1,1,,170464840,4075,Inactive,,,28.1838,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel",Confirmatory,,
935,1117326,1,1,,170464840,4075,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
936,1117329,1,1,,170464840,4075,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
937,1117336,1,1,,170464840,4075,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
938,1117340,1,1,,170464840,4075,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
939,1117341,1,1,,170464840,4075,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
940,1117342,1,1,,170464840,4075,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
941,1117343,1,1,,170464840,4075,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
942,1117346,1,1,,170464840,4075,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
943,1159509,1,1,,144208808,4075,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
944,1159509,1,1,,144213442,4075,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
945,1159509,1,1,,170464840,4075,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
946,1159515,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
947,1159515,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
948,1159515,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
949,1159516,1,1,,144208808,4075,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
950,1159516,1,1,,144213442,4075,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
951,1159516,1,1,,170464840,4075,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
952,1159517,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
953,1159517,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
954,1159517,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
955,1159518,1,1,,144208808,4075,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
956,1159518,1,1,,144213442,4075,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
957,1159518,1,1,,170464840,4075,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
958,1159519,1,1,,144208808,4075,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
959,1159519,1,1,,144213442,4075,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
960,1159519,1,1,,170464840,4075,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
961,1159520,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
962,1159520,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
963,1159520,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
964,1159521,1,1,,144208808,4075,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
965,1159521,1,1,,144213442,4075,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
966,1159521,1,1,,170464840,4075,Inactive,15928672.0,19885.0,0.1883,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
967,1159523,1,1,,144208808,4075,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
968,1159523,1,1,,144213442,4075,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
969,1159523,1,1,,170464840,4075,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
970,1159525,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
971,1159525,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
972,1159525,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
973,1159526,1,1,,144208808,4075,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
974,1159526,1,1,,144213442,4075,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
975,1159526,1,1,,170464840,4075,Inconclusive,119627033.0,3725.0,23.9145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
976,1159527,1,1,,144208808,4075,Inconclusive,325495497.0,6256.0,48.5591,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
977,1159527,1,1,,144213442,4075,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
978,1159527,1,1,,170464840,4075,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
979,1159528,1,1,,144208808,4075,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
980,1159528,1,1,,144213442,4075,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
981,1159528,1,1,,170464840,4075,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
982,1159529,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
983,1159529,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
984,1159529,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
985,1159531,1,1,,144208808,4075,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
986,1159531,1,1,,144213442,4075,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
987,1159531,1,1,,170464840,4075,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
988,1159551,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
989,1159551,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
990,1159551,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
991,1159552,1,1,,144208808,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
992,1159552,1,1,,144213442,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
993,1159552,1,1,,170464840,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
994,1159553,2,1,,144208808,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
995,1159553,2,1,,144213442,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
996,1159553,2,1,,170464840,4075,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
997,1159555,1,1,,144208808,4075,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
998,1159555,1,1,,144213442,4075,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
999,1159555,1,1,,170464840,4075,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1000,1159607,2,1,,312309909,4075,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1001,1159614,1,2,,170464840,4075,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1002,1159620,1,1,,103194285,4075,Active,,,,,Summary of drug indications.,Other,,
1003,1159935,1,2,,103194285,4075,Active,13432234.0,5468.0,,,Peroxisome proliferator-activated receptor gamma agonist,Other,15824083.0,
1004,1159935,1,2,,103194285,4075,Active,13432234.0,5468.0,,,Peroxisome proliferator-activated receptor gamma agonist,Other,18077625.0,
1005,1159935,1,2,,103194285,4075,Active,13432234.0,5468.0,,,Peroxisome proliferator-activated receptor gamma agonist,Other,18544567.0,
1006,1174762,1,1,,103194285,4075,Unspecified,,,,,Antiinflammatory activity against carrageenan-induced ip dosed Wistar rat paw edema model assessed as inhibition of edema administered 30 mins prior to carrageenan challenge measured after 60 mins,Other,25462274.0,
1007,1204222,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 1 hr relative to control",Other,25937011.0,
1008,1204224,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 2 hrs relative to control",Other,25937011.0,
1009,1204226,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 3 hrs relative to control",Other,25937011.0,
1010,1204228,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 4 hrs relative to control",Other,25937011.0,
1011,1204230,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 24 hrs relative to control",Other,25937011.0,
1012,1204231,1,1,,103194285,4075,Unspecified,,,,,"Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema at 10 mg/kg indomethacin mol equivalent, ip administered 1 hr prior to carrageenan challenge measured at 3 hrs relative to indomethacin",Other,25937011.0,
1013,1215351,1,2,,103194285,4075,Unspecified,12643959.0,10599.0,,,Inhibition of human OATP1B1 expressed HEK293 cells assessed as inhibition of [3H]sulfobromophthalein uptake by liquid scintillation counting,Other,21430235.0,
1014,1215352,1,2,,103194285,4075,Unspecified,1171882.0,6579.0,,,Inhibition of human OATP1A2 expressed HEK293 cells assessed as inhibition of [3H]sulfobromophthalein uptake by liquid scintillation counting,Other,21430235.0,
1015,1215353,1,2,,103194285,4075,Unspecified,27734563.0,28234.0,,,Inhibition of human OATP1B3 expressed HEK293 cells assessed as inhibition of [3H]sulfobromophthalein uptake by liquid scintillation counting,Other,21430235.0,
1016,1215354,1,2,,103194285,4075,Unspecified,313104012.0,11309.0,,,Inhibition of human OATP2B1 expressed HEK293 cells assessed as inhibition of [3H]sulfobromophthalein uptake by liquid scintillation counting,Other,21430235.0,
1017,1215355,1,2,,103194285,4075,Unspecified,313104012.0,11309.0,,,Drug uptake in human OATP2B1 expressed HEK293 cells at 20 uM relative to control cells,Other,21430235.0,
1018,1215356,1,2,,103194285,4075,Unspecified,27734563.0,28234.0,,,Drug uptake in human OATP1B3 expressed HEK293 cells at 20 uM relative to control cells,Other,21430235.0,
1019,1215357,1,2,,103194285,4075,Unspecified,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells at 20 uM relative to control cells,Other,21430235.0,
1020,1215358,1,2,,103194285,4075,Unspecified,313104012.0,11309.0,,,Drug uptake in human OATP2B1 expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1021,1215359,1,2,,103194285,4075,Unspecified,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1022,1215360,1,2,,103194285,4075,Unspecified,27734563.0,28234.0,,,Drug uptake in human OATP1B3 expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1023,1215361,1,2,,103194285,4075,Unspecified,313104012.0,11309.0,188.9,Km,Drug uptake in human OATP2B1 expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1024,1215362,1,2,,103194285,4075,Unspecified,27734563.0,28234.0,77.4,Km,Drug uptake in human OATP1B3 expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1025,1215363,1,2,,103194285,4075,Unspecified,12643959.0,10599.0,55.1,Km,Drug uptake in human OATP1B1 expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1026,1215364,1,1,,103194285,4075,Unspecified,,,55.1,Km,Drug uptake in human SCLO1B1*1a mutant expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1027,1215365,1,1,,103194285,4075,Active,,,16.3,Km,Drug uptake in human SCLO1B1*1b mutant expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1028,1215366,1,1,,103194285,4075,Active,,,24.3,Km,Drug uptake in human SCLO1B1*5 mutant expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1029,1215367,1,1,,103194285,4075,Active,,,32.4,Km,Drug uptake in human SCLO1B1*15 mutant expressed HEK293 cells assessed as net uptake,Confirmatory,21430235.0,
1030,1215368,1,1,,103194285,4075,Unspecified,,,,,Drug uptake in human SCLO1B1*1a mutant expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1031,1215369,1,1,,103194285,4075,Unspecified,,,,,Drug uptake in human SCLO1B1*1b mutant expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1032,1215370,1,1,,103194285,4075,Unspecified,,,,,Drug uptake in human SCLO1B1*5 mutant expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1033,1215371,1,1,,103194285,4075,Unspecified,,,,,Drug uptake in human SCLO1B1*15 mutant expressed HEK293 cells assessed as net uptake measured per mg of protein,Other,21430235.0,
1034,1215372,1,2,,103194285,4075,Inactive,313104012.0,11309.0,,,Drug uptake in human OATP2B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM pravastatin,Other,21430235.0,
1035,1215373,1,2,,103194285,4075,Inactive,27734563.0,28234.0,,,Drug uptake in human OATP1B3 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM pravastatin,Other,21430235.0,
1036,1215374,1,2,,103194285,4075,Inactive,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM pravastatin,Other,21430235.0,
1037,1215375,1,2,,103194285,4075,Inactive,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 10 uM pravastatin,Other,21430235.0,
1038,1215376,1,2,,103194285,4075,Inactive,313104012.0,11309.0,,,Drug uptake in human OATP2B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM cyclosporine,Other,21430235.0,
1039,1215377,1,2,,103194285,4075,Inactive,27734563.0,28234.0,,,Drug uptake in human OATP1B3 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM cyclosporine,Other,21430235.0,
1040,1215378,1,2,,103194285,4075,Inactive,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 100 uM cyclosporine,Other,21430235.0,
1041,1215379,1,2,,103194285,4075,Inactive,313104012.0,11309.0,,,Drug uptake in human OATP2B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 10 to 100 uM budesonide,Other,21430235.0,
1042,1215380,1,2,,103194285,4075,Inactive,27734563.0,28234.0,,,Drug uptake in human OATP1B3 expressed HEK293 cells at 20 uM relative to control cells in presence of 10 to 100 uM budesonide,Other,21430235.0,
1043,1215381,1,2,,103194285,4075,Inactive,12643959.0,10599.0,,,Drug uptake in human OATP1B1 expressed HEK293 cells at 20 uM relative to control cells in presence of 10 to 100 uM budesonide,Other,21430235.0,
1044,1224834,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1045,1224834,3,1,,144213442,4075,Inconclusive,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1046,1224834,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1047,1224835,1,1,,144208808,4075,Inconclusive,160794.0,,88.6299,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1048,1224835,1,1,,144213442,4075,Inconclusive,160794.0,,22.4458,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1049,1224835,1,1,,170464840,4075,Inconclusive,160794.0,,15.4871,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1050,1224836,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1051,1224836,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1052,1224836,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1053,1224837,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1054,1224837,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1055,1224837,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1056,1224838,1,1,,144208808,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1057,1224838,1,1,,144213442,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1058,1224838,1,1,,170464840,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1059,1224839,1,1,,144208808,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1060,1224839,1,1,,144213442,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1061,1224839,1,1,,170464840,4075,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1062,1224840,3,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1063,1224840,3,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1064,1224840,3,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1065,1224841,3,1,,144208808,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1066,1224841,3,1,,144213442,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1067,1224841,3,1,,170464840,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1068,1224842,3,1,,144208808,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1069,1224842,3,1,,144213442,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1070,1224842,3,1,,170464840,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1071,1224843,1,1,,144208808,4075,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1072,1224843,1,1,,144213442,4075,Inconclusive,119601739.0,7253.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1073,1224843,1,1,,170464840,4075,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1074,1224844,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1075,1224844,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1076,1224844,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1077,1224845,1,1,,144208808,4075,Inconclusive,344243002.0,100757539.0,28.1434,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1078,1224845,1,1,,144213442,4075,Inconclusive,344243002.0,100757539.0,50.4772,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1079,1224845,1,1,,170464840,4075,Inconclusive,344243002.0,100757539.0,19.5845,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1080,1224846,1,1,,144208808,4075,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1081,1224846,1,1,,144213442,4075,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1082,1224846,1,1,,170464840,4075,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1083,1224847,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1084,1224847,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1085,1224847,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1086,1224848,3,1,,144208808,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1087,1224848,3,1,,144213442,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1088,1224848,3,1,,170464840,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1089,1224849,3,1,,144208808,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1090,1224849,3,1,,144213442,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1091,1224849,3,1,,170464840,4075,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1092,1224852,2,1,,170464840,4075,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human neural progenitor cells (hNPCs),Confirmatory,,
1093,1224853,2,1,,170464840,4075,Inactive,,,,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1094,1224854,2,1,,170464840,4075,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytoma cells,Confirmatory,,
1095,1224855,2,1,,170464840,4075,Inactive,,,,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1096,1224856,2,1,,170464840,4075,Inactive,,,,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytes,Confirmatory,,
1097,1224857,2,1,,170464840,4075,Inconclusive,,,10.0,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1098,1224858,2,1,,170464840,4075,Inactive,,,,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytes,Confirmatory,,
1099,1224859,2,1,,170464840,4075,Inconclusive,,,31.6228,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1100,1224860,2,1,,170464840,4075,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1101,1224861,2,1,,170464840,4075,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytes,Confirmatory,,
1102,1224862,2,1,,170464840,4075,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytoma cell line (SNB-19),Confirmatory,,
1103,1224863,1,1,,176484285,4075,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1104,1224863,1,1,,176484697,4075,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1105,1224863,1,1,,316919506,4075,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1106,1224867,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1107,1224867,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1108,1224867,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1109,1224868,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1110,1224868,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1111,1224868,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1112,1224869,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1113,1224869,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1114,1224869,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1115,1224870,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1116,1224870,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1117,1224870,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1118,1224871,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1119,1224871,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1120,1224871,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1121,1224872,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1122,1224872,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1123,1224872,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1124,1224873,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1125,1224873,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1126,1224873,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1127,1224874,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1128,1224874,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1129,1224874,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1130,1224875,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1131,1224875,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1132,1224875,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1133,1224876,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1134,1224876,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1135,1224876,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1136,1224877,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1137,1224877,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1138,1224877,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1139,1224878,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1140,1224878,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1141,1224878,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1142,1224879,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1143,1224879,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1144,1224879,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1145,1224880,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1146,1224880,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1147,1224880,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1148,1224881,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1149,1224881,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1150,1224881,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1151,1224882,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1152,1224882,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1153,1224882,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1154,1224883,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1155,1224883,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1156,1224883,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1157,1224884,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1158,1224884,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1159,1224884,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1160,1224885,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1161,1224885,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1162,1224885,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1163,1224886,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1164,1224886,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1165,1224886,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1166,1224887,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1167,1224887,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1168,1224887,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1169,1224888,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1170,1224888,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1171,1224888,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1172,1224889,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1173,1224889,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1174,1224889,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1175,1224890,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1176,1224890,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1177,1224890,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1178,1224892,1,1,,144208808,4075,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1179,1224892,1,1,,144213442,4075,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1180,1224892,1,1,,170464840,4075,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1181,1224893,1,1,,144208808,4075,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1182,1224893,1,1,,144213442,4075,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1183,1224893,1,1,,170464840,4075,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1184,1224894,1,1,,144208808,4075,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1185,1224894,1,1,,144213442,4075,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1186,1224894,1,1,,170464840,4075,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1187,1224895,1,1,,144208808,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1188,1224895,1,1,,144213442,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1189,1224895,1,1,,170464840,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1190,1224896,1,1,,144208808,4075,Inconclusive,344243002.0,100757539.0,65.4701,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1191,1224896,1,1,,144213442,4075,Inconclusive,344243002.0,100757539.0,71.3009,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1192,1224896,1,1,,170464840,4075,Inconclusive,344243002.0,100757539.0,41.3916,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1193,1224905,2,1,,92309165,4075,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1194,1224905,2,1,,92309165,4075,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1195,1252320,1,1,,103194285,4075,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 0.01 to 1 mM after 30 mins,Other,26183083.0,
1196,1259241,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1197,1259241,1,1,,144213442,4075,Inconclusive,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1198,1259241,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1199,1259242,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1200,1259242,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1201,1259242,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1202,1259243,1,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1203,1259243,1,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1204,1259243,1,1,,170464840,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1205,1259244,1,1,,144208808,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1206,1259244,1,1,,144213442,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1207,1259244,1,1,,170464840,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1208,1259247,1,1,,144208808,4075,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1209,1259247,1,1,,144213442,4075,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1210,1259247,1,1,,170464840,4075,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1211,1259248,1,1,,144208808,4075,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1212,1259248,1,1,,144213442,4075,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1213,1259248,1,1,,170464840,4075,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1214,1259251,1,1,,46386870,4075,Active,,,,,AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of Unc-51 Like Autophagy Activating Kinase 1 (ULK1).,Screening,,
1215,1259310,1,1,,46386870,4075,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1216,1259310,1,1,,333473249,4075,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1217,1259310,1,1,,333473488,4075,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1218,1259325,1,2,,336954610,4075,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
1219,1259344,1,1,,144203935,4075,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1220,1259355,1,1,,26752847,4075,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1221,1259356,1,1,,144203935,4075,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1222,1259364,1,1,,144208808,4075,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1223,1259364,1,1,,144213442,4075,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1224,1259364,1,1,,170464840,4075,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1225,1259365,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1226,1259365,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1227,1259365,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1228,1259366,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1229,1259366,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1230,1259366,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1231,1259367,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1232,1259367,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1233,1259367,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1234,1259368,1,1,,144208808,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1235,1259368,1,1,,144213442,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1236,1259368,1,1,,170464840,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1237,1259369,1,1,,144208808,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1238,1259369,1,1,,144213442,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1239,1259369,1,1,,170464840,4075,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1240,1259377,1,1,,144208808,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1241,1259377,1,1,,144213442,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1242,1259377,1,1,,170464840,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1243,1259378,1,1,,144208808,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1244,1259378,1,1,,144213442,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1245,1259378,1,1,,170464840,4075,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1246,1259379,1,1,,144208808,4075,Inconclusive,,,60.5715,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1247,1259379,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1248,1259379,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1249,1259380,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1250,1259380,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1251,1259380,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1252,1259381,1,1,,144208808,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1253,1259381,1,1,,144213442,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1254,1259381,1,1,,170464840,4075,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1255,1259382,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1256,1259382,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1257,1259382,1,1,,170464840,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1258,1259383,1,1,,144208808,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1259,1259383,1,1,,144213442,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1260,1259383,1,1,,170464840,4075,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1261,1259384,1,1,,144208808,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1262,1259384,1,1,,144213442,4075,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1263,1259384,1,1,,170464840,4075,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1264,1259385,1,1,,144208808,4075,Inconclusive,119601739.0,7253.0,67.9623,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1265,1259385,1,1,,144213442,4075,Inconclusive,119601739.0,7253.0,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1266,1259385,1,1,,170464840,4075,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1267,1259386,1,1,,144208808,4075,Active,,,48.1136,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1268,1259386,1,1,,144213442,4075,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1269,1259386,1,1,,170464840,4075,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1270,1259387,1,1,,144208808,4075,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1271,1259387,1,1,,144213442,4075,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1272,1259387,1,1,,170464840,4075,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1273,1259388,1,1,,144208808,4075,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1274,1259388,1,1,,144213442,4075,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1275,1259388,1,1,,170464840,4075,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1276,1259389,1,1,,124658836,4075,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1277,1259390,1,1,,144208808,4075,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1278,1259390,1,1,,144213442,4075,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1279,1259390,1,1,,170464840,4075,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1280,1259391,1,1,,144208808,4075,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1281,1259391,1,1,,144213442,4075,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1282,1259391,1,1,,170464840,4075,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1283,1259392,1,1,,144208808,4075,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1284,1259392,1,1,,144213442,4075,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1285,1259392,1,1,,170464840,4075,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1286,1259393,1,1,,144208808,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1287,1259393,1,1,,144213442,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1288,1259393,1,1,,170464840,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1289,1259394,1,1,,144208808,4075,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1290,1259394,1,1,,144213442,4075,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1291,1259394,1,1,,170464840,4075,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1292,1259395,1,1,,144208808,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1293,1259395,1,1,,144213442,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1294,1259395,1,1,,170464840,4075,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1295,1259396,1,1,,144208808,4075,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1296,1259396,1,1,,144213442,4075,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1297,1259396,1,1,,170464840,4075,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1298,1259400,1,1,,170464840,4075,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1299,1259401,1,1,,144208808,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1300,1259401,1,1,,144213442,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1301,1259401,1,1,,170464840,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1302,1259402,1,1,,144208808,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1303,1259402,1,1,,144213442,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1304,1259402,1,1,,170464840,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1305,1259403,1,1,,144208808,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1306,1259403,1,1,,144213442,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1307,1259403,1,1,,170464840,4075,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1308,1259404,1,1,,144208808,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1309,1259404,1,1,,144213442,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1310,1259404,1,1,,170464840,4075,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1311,1259407,1,1,,363905284,4075,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1312,1259413,1,2,,46386870,4075,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
1313,1259416,1,2,,340083340,4075,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1314,1259421,1,1,,340083340,4075,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1315,1259423,1,2,,354913557,4075,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1316,1259423,1,2,,354967935,4075,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
